Search
Bromotheophylline
go.drugbank.com/drugs/DB14018Approved[L1082] It is also approved by Health Canada to be used alone or in combination with [DB00316] in OTC products.[L1113] … [A33018] Bromotheophylline is categorized on the FDA as a drug substance with an inactive state since March, 1980.
Mixtures: Uphamol Menstrual Tablet 500/25mg, Pain Aid PMFDegenerative Joint Disease of Hip
go.drugbank.com/conditions/DBCOND0110588Drugs: DiacereinSynonyms: Osteoarthritis in the Hip Joint, Osteoarthritis and allied disordersCrovalimab
go.drugbank.com/drugs/DB16128ApprovedInvestigational[A263958] It soon gained its approval in Japan in the next month,[A263958] and in the USA in June of the same year. … [L50908] First developed by Chugai Pharmaceutical, in collaboration with Roche, crovalimab was first approved in China in February 2024 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsIvacaftor
go.drugbank.com/drugs/DB08820ApprovedInvestigationalIt was approved by the Food and Drug Administration on January 31, 2012[L768], and by Health Canada in late 2012. … , an ion channel involved in the transport of chloride and sodium ions across cell membranes.
Categories: ivacaftor and tezacaftor, ivacaftor and lumacaftorSynonyms: N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamideCholine C 11
go.drugbank.com/drugs/DB09277Approved[A32041] It was developed by MCPRF and FDA first approved in September 2012. … Choline C 11 is a marker for cellular proliferation as its main molecule is a precursor for the biosynthesis of phospholipids which are essential components of all cell membranes.
Efgartigimod alfa
go.drugbank.com/drugs/DB15270ApprovedInvestigationalMyasthenia gravis (MG) is an autoimmune disorder characterized by significant muscle weakness - particularly in the eye, throat, and extremities - caused by autoantibodies attacking the neuromuscular junction … and a reduction in electrical nerve impulses.
Categories: Antineoplastic and Immunomodulating AgentsTafenoquine
go.drugbank.com/drugs/DB06608ApprovedInvestigationalTafenoquine is an 8-aminoquinoline analogue of primaquine which varies only on the presence of a 5-phenoxy group. … [A35671, A35690] It was discovered by the scientists at the Walter Reed Army Institute of Research in 1978 as a substitute for primaquine that would be more effective against relapsing vivax malaria.
Categories: Antiparasitic Products, Insecticides and RepellentsQXL138AM
go.drugbank.com/drugs/DB18552InvestigationalQXL138AM is a masked immunocytokine (MIC) comprised of an anti-CD138 immunoglobulin G1 antibody fused to interferon alpha 2a. It binds the CD138 protein on the surface of the tumour cells.
Synonyms: Masked immunocytokine (MIC) comprised of an anti-CD138 immunoglobulin G1 antibody fused to interferon alpha 2aAcute angle-closure glaucoma
go.drugbank.com/conditions/DBCOND0024238Synonyms: Glaucoma closed angle, Angle glaucoma closedSimeprevir
go.drugbank.com/drugs/DB06290ApprovedWithdrawnLike all NS3/4A inhibitors, simeprevir is a serine protease inhibitor in similarity to [DB08873] and [DB05521] but is classified as a second generation protease inhibitor. … Simeprevir was approved by the FDA in November 2014 and is marketed under the brand name Olysio as oral tablets.
Categories: Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics